GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gossamer Bio Inc (FRA:4GB) » Definitions » Sale Of Investment

Gossamer Bio (FRA:4GB) Sale Of Investment : €362.55 Mil (TTM As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Gossamer Bio Sale Of Investment?

Gossamer Bio's sale of investment for the three months ended in Mar. 2024 was €135.98 Mil. It means Gossamer Bio gained €135.98 Mil from selling investments. Gossamer Bio's sale of investment for the trailing twelve months (TTM) ended in Mar. 2024 was €362.55 Mil.

Compared with last quarter (€97.11 Mil in Dec. 2023 ), Gossamer Bio gained more money from selling investments in Mar. 2024 (€135.98 Mil).


Gossamer Bio Sale Of Investment Historical Data

The historical data trend for Gossamer Bio's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gossamer Bio Sale Of Investment Chart

Gossamer Bio Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sale Of Investment
Get a 7-Day Free Trial 322.65 287.04 32.06 224.20 303.25

Gossamer Bio Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 79.95 64.06 65.40 97.11 135.98

Gossamer Bio Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €362.55 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gossamer Bio Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Gossamer Bio's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Gossamer Bio (FRA:4GB) Business Description

Traded in Other Exchanges
Address
3013 Science Park Road, Suite 200, San Diego, CA, USA, 92121
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

Gossamer Bio (FRA:4GB) Headlines

No Headlines